Although our in vitro and in vivo studies have indicated a critical role of MDM2 in JapA's anticancer activity, further investigations on the identification and validation of mechanisms using cutting-edge techniques and state-of-the-art cancer models are required. The gene discussed is MDM2; the disease is cancer.